The Scientist

» FDA and immunology

Most Recent

image: Biomedical Research Bill Approved in House

Biomedical Research Bill Approved in House

By | December 1, 2016

The 21st Century Cures Act could provide funds to federal research agencies for the decade and accelerate the drug approval process.

1 Comment

image: Trump Announces HHS, CMS Picks

Trump Announces HHS, CMS Picks

By | November 30, 2016

President-elect Donald Trump chooses Representative Tom Price to lead the Department of Health and Human Services, Seema Verma to lead the Centers for Medicare and Medicaid Services.

1 Comment

image: Low Social Status May Weaken Immune System in Monkeys

Low Social Status May Weaken Immune System in Monkeys

By | November 29, 2016

Life at the bottom of the pecking order ramps up inflammation, according to new research, an effect that appears to be reversible.

0 Comments

image: More than 40 New Papers on Epigenetics Published

More than 40 New Papers on Epigenetics Published

By | November 22, 2016

The International Human Epigenome Consortium presents a series of studies on how epigenetics influences immunity, cell lineage determination, and differentiation.

0 Comments

image: Contributors

Contributors

By | November 1, 2016

Meet some of the people featured in the November 2016 issue of The Scientist.

0 Comments

image: Nosing Around

Nosing Around

By | November 1, 2016

Covering neuroscience research means choosing from an embarrassment of riches.

0 Comments

image: Viruses of the Human Body

Viruses of the Human Body

By | November 1, 2016

Some of our resident viruses may be beneficial.

4 Comments

image: Immune System Maintains Brain Health

Immune System Maintains Brain Health

By | November 1, 2016

Once thought only to attack neurons, immune cells turn out to be vital for central nervous system function.

3 Comments

image: Immunity in the Brain

Immunity in the Brain

By | November 1, 2016

Researchers document the diverse roles of immune cells in neuronal health and disease.

0 Comments

An early-stage study of the effectiveness of a lung-cancer vaccine developed by scientists in Cuba could start as early as next month.

0 Comments

Popular Now

  1. A Coral to Outlast Climate Change
  2. Antarctica Is Turning Green
  3. First In Vivo Human Genome Editing to Be Tested in New Clinical Trial
  4. Science Celebrities: Where Are the Women?
AAAS